Ozempic
Ozempic Launches in India: Novo Nordisk's Diabetes and Weight Loss Drug Enters World's Second-Largest Diabetes Market
Dec 12, 2025 05:46 pm CST
Novo Nordisk has introduced Ozempic to the Indian market, pricing the diabetes medication at Rs 8,800-11,175 monthly across three dosages. The strategic launch targets India's significant diabetic population before generic competitors arrive in 2026. Beyond blood sugar control, Ozempic offers weight loss benefits and reduced cardiovascular risks, but remains prescription-restricted for medical use only.
Nobel Prize 2023: Appetite-Regulating Hormone Research Takes Center Stage in Medicine Award Predictions
Oct 06, 2025 04:39 pm CST
The Nobel Prize in Medicine 2023 may recognize groundbreaking research on GLP-1 and other appetite-regulating hormones that have revolutionized obesity and diabetes treatment. With medications like Ozempic and Wegovy demonstrating significant clinical success, researchers behind these discoveries are frontrunners for the prestigious award, while concerns grow about US science funding cuts potentially threatening America's leadership in scientific innovation.
At Wellness Resorts, Ozempic Becomes Part Of The Treatment Menu
Sep 17, 2025 02:51 am CST
A 2024 KFF survey found that about 1 in 8 US adults have used a GLP-1 drug like Ozempic.